Colazal (balsalazide disodium) 750mg capsules
Mfg: Salix Pharmaceuticals, Inc.
Indication(s): Mildly to moderately active ulcerative colitis. Safety and effectiveness beyond 12 weeks has not been established.
Dosage & Administration: (3) 750mg capsules three times daily for a duration of from 8 to up to 12 weeks.
Pharmacology: Converted to mesalamine in the colon and appears to have topical rather than systemic action and may include decreased inflammation by 5-aminosalicylic acid inhibition of arachidonic acid metabolites.
WebRx Editorial Notes: Seems like a "me-too" like Asacol and sulfasalazine. Stay tuned.
©2001 WebRx Pharmacy Palace